Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Cholangitis | Case Report

Cholangitis with bacteremia due to Pseudomonas nitroreducens in a patient with pancreatic neuroendocrine tumors: a case report

Authors: Naoya Itoh, Nana Akazawa, Makoto Yamaguchi, Hiromi Murakami, Kiyofumi Ohkusu

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Pseudomonas nitroreducens is a non-fermenting, gram-negative, rod-shaped bacterium commonly inhabiting soil, particularly soil contaminated with oil brine. To our knowledge, no cases of human infection with P. nitroreducens have been previously reported. Here, we present the first documented case of cholangitis caused by P. nitroreducens in a patient with bacteremia.

Case presentation

A 46-year-old Japanese man with an advanced pancreatic neuroendocrine tumor was hospitalized with fever and chills. Four days before admission, the patient developed right upper abdominal pain. Two days later, he also experienced fever and chills. Endoscopic retrograde cholangiopancreatography was performed on the day of admission, and the patient was diagnosed as having cholangitis associated with stent dysfunction. Gram-negative rods were isolated from blood cultures, but attempts to identify the bacteria using VITEK2 and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with VITEK MS ver. 4.7.1 (bioMérieux Japan Co. Ltd., Tokyo, Japan) were unsuccessful. Finally, the organism was identified as P. nitroreducens using MALDI-TOF MS with a MALDI Biotyper (Bruker Daltonics Co., Ltd., Billerica, MA, USA) and 16 S ribosomal RNA sequencing. Despite thorough interviews with the patient, he denied any exposure to contaminated soil. The patient was treated with intravenous cefepime and oral ciprofloxacin for 16 days based on susceptibility results, achieving a good therapeutic outcome. At the outpatient follow-up on day 28, the patient was in good general condition.

Conclusions

This is the first reported human case of cholangitis with bloodstream infection caused by P. nitroreducens. This report provides clinicians with novel insights into the clinical manifestations and diagnostic methods necessary for the accurate diagnosis of P. nitroreducens, along with guidance on treatment.
Literature
1.
go back to reference Iizuka H, Komagata K. Microbiological studies on petroleum and natural gas. I. determination of hydrocarbon-utilizing bacteria. J Gen Appl Microbiol. 1964;10:207–21.CrossRef Iizuka H, Komagata K. Microbiological studies on petroleum and natural gas. I. determination of hydrocarbon-utilizing bacteria. J Gen Appl Microbiol. 1964;10:207–21.CrossRef
2.
go back to reference Huang SL, Chen H, Hu A, Tuan NN, Yu CP. Draft genome sequence of Pseudomonas nitroreducens strain TX1, which degrades nonionic surfactants and estrogen-like alkylphenols. Genome Announc. 2014;2:e01262–13.CrossRefPubMedPubMedCentral Huang SL, Chen H, Hu A, Tuan NN, Yu CP. Draft genome sequence of Pseudomonas nitroreducens strain TX1, which degrades nonionic surfactants and estrogen-like alkylphenols. Genome Announc. 2014;2:e01262–13.CrossRefPubMedPubMedCentral
3.
go back to reference Iyer R, Iken B, Damania A. Genome of Pseudomonas nitroreducens DF05 from dioxin contaminated sediment downstream of the San Jacinto River waste pits reveals a broad array of aromatic degradation gene determinants. Genom Data. 2017;14:40–3.CrossRefPubMedPubMedCentral Iyer R, Iken B, Damania A. Genome of Pseudomonas nitroreducens DF05 from dioxin contaminated sediment downstream of the San Jacinto River waste pits reveals a broad array of aromatic degradation gene determinants. Genom Data. 2017;14:40–3.CrossRefPubMedPubMedCentral
4.
go back to reference Yao J, Zhang G, Wu Q, Chen GQ, Zhang R. Production of polyhydroxyalkanoates by Pseudomonas nitroreducens. Antonie Van Leeuwenhoek. 1999;75:345–9.CrossRefPubMed Yao J, Zhang G, Wu Q, Chen GQ, Zhang R. Production of polyhydroxyalkanoates by Pseudomonas nitroreducens. Antonie Van Leeuwenhoek. 1999;75:345–9.CrossRefPubMed
5.
go back to reference Turner TL, Wunderink R, Ozer E, Hauser A. First report of Pseudomonas nitroreducens cultured from the lungs of a patient with pneumonia. BMJ Case Rep. 2021;14:e241327.CrossRefPubMedPubMedCentral Turner TL, Wunderink R, Ozer E, Hauser A. First report of Pseudomonas nitroreducens cultured from the lungs of a patient with pneumonia. BMJ Case Rep. 2021;14:e241327.CrossRefPubMedPubMedCentral
7.
go back to reference Wagner J, Short K, Catto-Smith AG, Cameron DJ, Bishop RF, Kirkwood CD. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn’s disease. PLoS ONE. 2008;3:e3578.ADSCrossRefPubMedPubMedCentral Wagner J, Short K, Catto-Smith AG, Cameron DJ, Bishop RF, Kirkwood CD. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn’s disease. PLoS ONE. 2008;3:e3578.ADSCrossRefPubMedPubMedCentral
8.
go back to reference Li M, Ma Q, Kong D, Han X, Che J, Zhou Y et al. Pseudomonas Nicosulfuronedens sp. nov., a nicosulfuron degrading bacterium, isolated from a microbial consortium. Int J Syst Evol Microbiol. 2021;71. Li M, Ma Q, Kong D, Han X, Che J, Zhou Y et al. Pseudomonas Nicosulfuronedens sp. nov., a nicosulfuron degrading bacterium, isolated from a microbial consortium. Int J Syst Evol Microbiol. 2021;71.
9.
go back to reference Arai K, Kawai K, Kohda W, Tatsu H, Matsui O, Nakahama T. Dynamic CT of acute cholangitis: early inhomogeneous enhancement of the liver. AJR Am J Roentgenol. 2003;181:115–8.CrossRefPubMed Arai K, Kawai K, Kohda W, Tatsu H, Matsui O, Nakahama T. Dynamic CT of acute cholangitis: early inhomogeneous enhancement of the liver. AJR Am J Roentgenol. 2003;181:115–8.CrossRefPubMed
10.
go back to reference Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.CrossRefPubMed Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.CrossRefPubMed
Metadata
Title
Cholangitis with bacteremia due to Pseudomonas nitroreducens in a patient with pancreatic neuroendocrine tumors: a case report
Authors
Naoya Itoh
Nana Akazawa
Makoto Yamaguchi
Hiromi Murakami
Kiyofumi Ohkusu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09092-8

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.